HACE1
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
154662copy number lossGRCh38/hg38 6q16.3(chr6:104501910-104729309)x1-1-6104949785105177184nana
154662copy number lossGRCh38/hg38 6q16.3(chr6:104501910-104729309)x1-1-6104501910104729309nana
154662copy number lossGRCh38/hg38 6q16.3(chr6:104501910-104729309)x1-1-6105056478105283877nana
163913copy number gainGRCh38/hg38 6q16.3(chr6:104094035-104885245)x3-1-6104541910105333120nana
163913copy number gainGRCh38/hg38 6q16.3(chr6:104094035-104885245)x3-1-6104094035104885245nana
163913copy number gainGRCh38/hg38 6q16.3(chr6:104094035-104885245)x3-1-6104648603105439813nana
223018single nucleotide variantNM_020771.3(HACE1):c.655C>T (p.Arg219Ter)869025280MedGen:CN235103,OMIM:6167566104796988104796988GA
223018single nucleotide variantNM_020771.3(HACE1):c.655C>T (p.Arg219Ter)869025280MedGen:CN235103,OMIM:6167566105244863105244863GA
223019single nucleotide variantNM_020771.3(HACE1):c.2242C>T (p.Arg748Ter)869025281MedGen:CN235103,OMIM:6167566104750442104750442GA
223019single nucleotide variantNM_020771.3(HACE1):c.2242C>T (p.Arg748Ter)869025281MedGen:CN235103,OMIM:6167566105198317105198317GA
223020insertionNM_020771.3(HACE1):c.2019_2020insTTTAGGTATTTTTAGGTATT (p.Pro674Phefs)869025282MedGen:CN235103,OMIM:6167566104771384104771385-AATACCTAAAAATACCTAAA
223020insertionNM_020771.3(HACE1):c.2019_2020insTTTAGGTATTTTTAGGTATT (p.Pro674Phefs)869025282MedGen:CN235103,OMIM:6167566105219259105219260-AATACCTAAAAATACCTAAA
223021deletionNM_020771.3(HACE1):c.2490_2492delTCT (p.Leu832del)869025283MedGen:CN235103,OMIM:6167566104744181104744183AGA-
223021deletionNM_020771.3(HACE1):c.2490_2492delTCT (p.Leu832del)869025283MedGen:CN235103,OMIM:6167566105192056105192058AGA-
223022deletionNM_020771.3(HACE1):c.1852_1853delCA (p.Gln618Valfs)751809418MedGen:CN235103,OMIM:6167566105224627105224628TG-
223022deletionNM_020771.3(HACE1):c.1852_1853delCA (p.Gln618Valfs)751809418MedGen:CN235103,OMIM:6167566104776752104776753TG-
223023single nucleotide variantNM_020771.3(HACE1):c.454C>T (p.Gln152Ter)869025284MedGen:CN235103,OMIM:6167566104833122104833122GA
223023single nucleotide variantNM_020771.3(HACE1):c.454C>T (p.Gln152Ter)869025284MedGen:CN235103,OMIM:6167566105280997105280997GA
223024single nucleotide variantNM_020771.3(HACE1):c.805C>T (p.Arg269Ter)750371878MedGen:CN235103,OMIM:6167566104796666104796666GA
223024single nucleotide variantNM_020771.3(HACE1):c.805C>T (p.Arg269Ter)750371878MedGen:CN235103,OMIM:6167566105244541105244541GA
223025single nucleotide variantNM_020771.3(HACE1):c.240C>A (p.Cys80Ter)761086584MedGen:CN235103,OMIM:6167566104849228104849228GT
223025single nucleotide variantNM_020771.3(HACE1):c.240C>A (p.Cys80Ter)761086584MedGen:CN235103,OMIM:6167566105297103105297103GT
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
6105180785rs4336470CTrs43364702.00E-04TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561TintronGWASdb_drug
6105184640rs9404576TGrs94045762.00E-04TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561GintronGWASdb_drug
6105191814rs6942231CTrs69422311.60E-04THYROTROPINCREATININE|CYSTATIN C|CYSTATINS|CST3 PROTEIN, HUMANKidney function and endocine traitsHPOID:0000083DOID:557TintronGWASdb_drug
6105232233rs9322817ACrs93228177.00E-06THYROTROPINCREATININE|CYSTATIN C|CYSTATINS|CST3 PROTEIN, HUMANThyroid stimulating hormoneHPOID:0011747DOID:7166|DOID:7998AintronGWASdb_drug
6105180785rs4336470CTrs43364702.70E-04Hemoglobin concentrationHPOID:0011902DOID:2860TintronGWASdb_trait
6105180785rs4336470CTrs43364702.00E-04Cognitive impairment induced by topiramateHPOID:0100543DOID:1561TintronGWASdb_trait
6105180785rs4336470CTrs43364703.00E-11NeuroblastomaHPOID:0003006DOID:769TintronGWASdb_trait
6105180785rs4336470CTrs43364707.91E-05NeuroblastomaHPOID:0003006DOID:769TintronGWASdb_trait
6105184640rs9404576TGrs94045761.62E-04Hemoglobin concentrationHPOID:0011902DOID:2860GintronGWASdb_trait
6105184640rs9404576TGrs94045762.00E-04Cognitive impairment induced by topiramateHPOID:0100543DOID:1561GintronGWASdb_trait
6105184640rs9404576TGrs94045761.80E-10NeuroblastomaHPOID:0003006DOID:769GintronGWASdb_trait
6105191814rs6942231CTrs69422311.60E-04Kidney function and endocine traitsHPOID:0000083DOID:557TintronGWASdb_trait
6105216695rs9322816TCrs93228163.71E-04Hemoglobin concentrationHPOID:0011902DOID:2860TintronGWASdb_trait
6105223864rs733724GArs7337243.00E-07Multiple sclerosisHPOID:0000096|HPOID:0001967|HPOID:0009741|HPOID:0008664|HPOID:0001150|HPOID:0005450|HPOID:0005652|HPOID:0005686|HPOID:0005789|HPOID:0100923|HPOID:0100925|HPOID:0006623|HPOID:0100861|HPOID:0002694|HPOID:0004979|HPOID:0003881|HPOID:0003991|HPOID:0003854|HPOID:0003933|HPOID:0004030|HPOID:0100899|HPOID:0002634DOID:2377GintronGWASdb_trait
6105229646rs17065302CGrs170653020.0000048Equol producers as measured by serum equol concentrationsNANACintronGWASdb_trait
6105232233rs9322817ACrs93228177.00E-06Thyroid stimulating hormoneHPOID:0011747DOID:7166|DOID:7998AintronGWASdb_trait
6105236302rs11759010TGrs117590100.0000038Equol producers as measured by serum equol concentrationsNANATintronGWASdb_trait
6105266118rs4079063AGrs40790631.30E-07NeuroblastomaHPOID:0003006DOID:769GintronGWASdb_trait
6105288125rs6927608ACrs69276080.0000025Equol producers as measured by serum equol concentrationsNANAAintronGWASdb_trait
6105295535rs4946645CGrs49466450.000003Equol producers as measured by serum equol concentrationsNANACintronGWASdb_trait
6105300570rs2499663CTrs24996631.60E-07NeuroblastomaHPOID:0003006DOID:769CintronGWASdb_trait
6105306144rs4245525CTrs42455250.0000079Equol producers as measured by serum equol concentrationsNANACintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000085382.11 HACE1 610876